Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine

Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine

Abstract Background Post-COVID-19 Condition (PCC), as defined by the World Health Organization (WHO), currently lacks any regulatory-approved treatments and is characterized by persistent and debilitating cognitive impairment and mood symptoms. Additionally, metabolic dysfunction, chronic inflammati...

Full description

Bibliographic Details
Main Authors: Angela T.H. Kwan, Gia Han Le, Ziji Guo, Felicia Ceban, Kayla M. Teopiz, Taeho Greg Rhee, Roger Ho, Joshua D. Di Vincenzo, Sebastian Badulescu, Shakila Meshkat, Bing Cao, Joshua D. Rosenblat, Donovan A. Dev, Lee Phan, Mehala Subramaniapillai, Roger S. McIntyre
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Annals of General Psychiatry
Subjects:
Long COVID
Vortioxetine
Cognitive function
Digit symbol substitution test (DSST)
Inflammation
Metabolic dysfunction
Online Access:https://doi.org/10.1186/s12991-024-00494-1

Internet

https://doi.org/10.1186/s12991-024-00494-1

Similar Items